Introduction This novel rat study with native peptide therapy focused on unresolved muscle-to-bone reattachment [1,2,3,4,5,6,7,8,9,10] and the stable gastric pentadecapeptide BPC 157 per-oral therapy, shared muscle healing, and function restoration [11,12,13,14]
The compound was first described in the 1990s by Predrag Sikiric and colleagues at the University of Zagreb, Croatia
Injection delivery is the only reliable way to maintain therapeutic levels for patients with absorption issues or rapid elimination
*Correspondence: Agata Blazewicz, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
And more importantly, is your body even able to use what you're taking